Evidence map›Paper›PMID 42901926›Full record

ArticleNature communications2026

Epithelial NF-κB shapes protective Treg cell responses to restrain intestinal inflammation.

Luisa Barleben, Antony Julián Schneegans, Bora Uyar, Alix Bruneau, Giomar Vasileva, Franziska Flohr, Eleni Kabrani, Thomas Vasilakis, Linda Hammann, Pimrapat Gebert and 17 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Luisa Barleben *Department of Hepatology and Gastroenterology, Campus Virchow-Klinikum and Campus Charité Mitte, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Antony Julián Schneegans *Department of Hepatology and Gastroenterology, Campus Virchow-Klinikum and Campus Charité Mitte, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Bora UyarBioinformatics and Omics Data Science Platform, Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine, Berlin, Germany.ORCID 0000-0002-3170-4890
Alix BruneauDepartment of Hepatology and Gastroenterology, Campus Virchow-Klinikum and Campus Charité Mitte, Charité - Universitätsmedizin Berlin, Berlin, Germany.ORCID 0000-0002-5740-2372
Giomar VasilevaDepartment of Hepatology and Gastroenterology, Campus Virchow-Klinikum and Campus Charité Mitte, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Franziska FlohrDepartment of Hepatology and Gastroenterology, Campus Virchow-Klinikum and Campus Charité Mitte, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Eleni KabraniLaboratory of Genome Diversification and Integrity, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.ORCID 0000-0003-0834-9912
Thomas VasilakisDepartment of Hepatology and Gastroenterology, Campus Virchow-Klinikum and Campus Charité Mitte, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Linda HammannInstitute of Clinical Pharmacology, Klinikum der Ludwig-Maximilians-Universität München, Munich, Germany.
Pimrapat GebertInstitute of Biometry and Clinical Epidemiology, Charité Universitätsmedizin Berlin, Berlin, Germany.ORCID 0000-0002-5946-7137
Carola DietrichGenomics Technology Platform, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
Bettina Bochow-FitznerDepartment of Hepatology and Gastroenterology, Campus Virchow-Klinikum and Campus Charité Mitte, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Alexander ArnoldDepartment of Pathology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Somesh SaiMax Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.ORCID 0000-0001-6865-341X
Florentine GröneDepartment of Hepatology and Gastroenterology, Campus Virchow-Klinikum and Campus Charité Mitte, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Maike SanderMax Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.ORCID 0000-0001-5308-7785
Thomas ConradGenomics Technology Platform, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.ORCID 0000-0001-5618-6295
Audrey GérardThe Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.ORCID 0000-0003-3059-3065
Ignazio PisedduInstitute of Clinical Pharmacology, Klinikum der Ludwig-Maximilians-Universität München, Munich, Germany.
David AnzInstitute of Clinical Pharmacology, Klinikum der Ludwig-Maximilians-Universität München, Munich, Germany.
Christoph JochumDepartment of Hepatology and Gastroenterology, Campus Virchow-Klinikum and Campus Charité Mitte, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Altuna AkalinBioinformatics and Omics Data Science Platform, Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine, Berlin, Germany.ORCID 0000-0002-0468-0117
Linda HammerichDepartment of Hepatology and Gastroenterology, Campus Virchow-Klinikum and Campus Charité Mitte, Charité - Universitätsmedizin Berlin, Berlin, Germany.ORCID 0000-0003-0557-3927
Christoph S N KloseCharité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Microbiology, Infectious Diseases and Immunology, Hindenburgdamm 30, Berlin, Germany.ORCID 0000-0001-8803-2979
Frank TackeDepartment of Hepatology and Gastroenterology, Campus Virchow-Klinikum and Campus Charité Mitte, Charité - Universitätsmedizin Berlin, Berlin, Germany.ORCID 0000-0001-6206-0226
Michela Di VirgilioLaboratory of Genome Diversification and Integrity, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.ORCID 0000-0001-5189-0793
Marina KolesnichenkoDepartment of Hepatology and Gastroenterology, Campus Virchow-Klinikum and Campus Charité Mitte, Charité - Universitätsmedizin Berlin, Berlin, Germany. marina.kolesnichenko@charite.de.ORCID 0000-0001-7366-9061

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammation resolution depends on coordinated communication between tissue compartments, yet how the intestinal epithelium shapes its immune microenvironment remains poorly understood. Here, using colonic biopsies from patients with ulcerative colitis (UC) and mouse models enabling tissue-wide visualization of NF-κB activity, we combine single-cell RNA sequencing and secretome analysis to define epithelial communication during colitis. We show that, paradoxically, the NF-κB-driven pro-inflammatory secretome of intestinal epithelial cells (IECs) is essential for recovery and prevents unrestrained inflammation. Mechanistically, epithelial NF-κB promotes CCL22-dependent regulatory T cell (Treg cell) recruitment and promotes a tolerogenic, pro-repair cell state, accompanied by induction of the lipid-metabolism-associated GDPD3 and CCR4. In UC, epithelial NF-κB is not uniformly activated but instead induces a selective pro-inflammatory transcriptional program while repressing targets regulating T cell recruitment. Thus, we identify dynamic epithelial-immune communication and demonstrate a protective IEC NF-κB-Treg cell axis important for resolution of intestinal inflammation.

Indexed as

Colitis, UlcerativeIntestinal MucosaNF-kappa BT-Lymphocytes, RegulatoryAnimalsChemokine CCL22ColonDisease Models, AnimalEpithelial CellsFemaleHumansInflammationMaleMiceMice, Inbred C57BLChemokine CCL22NF-kappa B

Identifiers

PMID42901926
PMCPMC13683377

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.